Autopsy report · NCT03056495

Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease

“Insufficient Recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 6 years 5 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

German Center for Neurodegenerative Diseases (DZNE)

Sponsor type

University, hospital or other

Conditions

Alzheimer Disease

Interventions

N-hydroxy-N'-phenyl-octanediamide (Vorinostat)

Participants

9

Sites

2

Countries

Germany

Trials that died the same way

• Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery
  “Recruitment insufficient” (96% match in meaning)
• Hypogonadotropic Hypogonadism in Obese Young Males
  “not enough recruitment” (91% match in meaning)
• Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens
  “Insufficient recruitment population.” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.